Literature DB >> 3978228

Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.

B C Wolf, R S Neiman.   

Abstract

We undertook a study of 35 cases of myelofibrosis with myeloid metaplasia to assess the histopathologic findings in the bone marrow of patients with this disorder, to ascertain if changes in morphology occurred with time, and to attempt to correlate marrow findings with splenic size. We reviewed 71 bone marrow biopsies and studied 13 splenectomy specimens. Sequential bone marrow biopsies were obtained in 21 cases over intervals ranging from two to ten years (mean, 4 1/2 years). We noted a patchy nature and variable degree of stromal proliferation in most marrow biopsies, and were unable to demonstrate a correlation between the extent of medullary fibrosis and duration of disease, splenic weight, or degree of splenic myeloid metaplasia. We were unable to document a progression of medullary fibrosis as a cause for increasing splenomegaly. However, the alteration in the marrow stroma in this disorder is responsible for the presence of distended marrow sinusoids with intravascular hematopoiesis, a phenomenon we observed in all cases. We believe that this morphological feature, not emphasized by previous investigators, is of significance in understanding the pathophysiology of myeloid metaplasia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978228

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  The spleen in osteomyelofibrosis. A morphological and immunohistochemical study of 30 cases.

Authors:  S Falk; D Mix; H J Stutte
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Idiopathic myelofibrosis in an infant.

Authors:  Rupali R Bavikar; Rajesh K Kulkarni; Ashok D Rathod; Meenal S Hastak
Journal:  Indian J Pediatr       Date:  2010-12-28       Impact factor: 1.967

Review 3.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Megakaryocytes and sinus walls in primary osteomyelofibrosis: transendothelial migration as revealed by three-dimensional reconstruction of serial sections following sequential double-immunostaining.

Authors:  J Thiele; H M Kvasnicka; T Amend; R Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Extramedullary Hematopoiesis of the Renal Pelvis in a Patient With Myelofibrosis.

Authors:  Michele Stanchina; Evan Rosenbaum; Alexander J Pronko; Yuzhou Liu; Natasha Lewis; Mariko Yabe; Eytan Stein; Justin Taylor
Journal:  J Oncol Pract       Date:  2019-06-17       Impact factor: 3.840

6.  Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.

Authors:  J Thiele; B Hoeppner; R Zankovich; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.

Authors:  G Barosi; L N Liberato; A Costa; E Ascari
Journal:  Blut       Date:  1989-06

8.  Assessment of bone marrow inflammation in patients with myelofibrosis: an 18F-fluorodeoxyglucose PET/CT study.

Authors:  Thorsten Derlin; Haefaa Alchalby; Peter Bannas; Simon Veldhoen; Ivayla Apostolova; Ioanna Triviai; Frank M Bengel; Nicolaus Kröger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-20       Impact factor: 9.236

9.  Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.

Authors:  G E Verhoef; C De Wolf-Peeters; A Ferrant; S Deprez; P Meeus; M Stul; P Zacheé; J J Cassiman; H Van den Berghe; M A Boogaerts
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

10.  Interleukin-7 (IL-7)-induced proliferation of CD8+ T-chronic lymphocytic leukemia cells.

Authors:  R Yoshioka; S Shimizu; J Tachibana; Y Hirose; M Fukutoku; Y Takeuchi; S Sugai; T Takiguchi; S Konda
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.